Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buchler

Showing results (441-450 of 502) with videos related to

Pageof 51
Sort By:
Biomedical Engineering Online|April 2, 2024
Noninvasive spinal stimulation improves walking in chronic stroke survivors: a proof-of-concept case seriesYaejin Moon, Chen Yang, Nicole C Veit, et al.
Journal of Medicinal Chemistry|October 2, 2018
Optimization of 8-Hydroxyquinolines as Inhibitors of Catechol O-MethyltransferaseIngrid Buchler, Daniel Akuma, Vinh Au, et al.
Therapeutic Drug Monitoring|February 2, 2016
A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant RecipientsAnne-Sophie Jannot, Xavier Vuillemin, Isabelle Etienne, et al.
Kidney International|November 4, 2024
Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipientsSophie Caillard, Nicolas Meyer, Morgane Solis, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 14, 2019
Etiology and Outcomes of Thrombotic MicroangiopathiesGuillaume Bayer, Florent von Tokarski, Benjamin Thoreau, et al.
International Journal of Cancer|June 9, 2023
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trialSun Young Rha, Toni K Choueiri, Vsevolod B Matveev, et al.
Scientific Reports|July 5, 2026
Early systemic inflammatory-metabolic trajectory phenotypes are associated with survival outcomes in metastatic renal cell carcinoma treated with nivolumabOndřej Fiala, Tomas Buchler, Alexandr Poprach, et al.
The New England Journal of Medicine|March 21, 2014
Ribavirin for chronic hepatitis E virus infection in transplant recipientsNassim Kamar, Jacques Izopet, Simona Tripon, et al.
Frontiers in Immunology|July 15, 2026
Nivolumab in previously treated metastatic renal cell carcinoma: real-world data from the Czech Republic and SlovakiaOndřej Fiala, Michaela Tkadlecová, Tomas Buchler, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 17, 2023
Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH StudyCaroline Monchaud, Jean-Baptiste Woillard, Sabrina Crépin, et al.
Pageof 51

Showing results (441-450 of 502) with videos related to

Sort By:
Pageof 51
Biomedical Engineering Online|April 2, 2024
Noninvasive spinal stimulation improves walking in chronic stroke survivors: a proof-of-concept case seriesYaejin Moon, Chen Yang, Nicole C Veit, et al.
Journal of Medicinal Chemistry|October 2, 2018
Optimization of 8-Hydroxyquinolines as Inhibitors of Catechol O-MethyltransferaseIngrid Buchler, Daniel Akuma, Vinh Au, et al.
Therapeutic Drug Monitoring|February 2, 2016
A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant RecipientsAnne-Sophie Jannot, Xavier Vuillemin, Isabelle Etienne, et al.
Kidney International|November 4, 2024
Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipientsSophie Caillard, Nicolas Meyer, Morgane Solis, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 14, 2019
Etiology and Outcomes of Thrombotic MicroangiopathiesGuillaume Bayer, Florent von Tokarski, Benjamin Thoreau, et al.
International Journal of Cancer|June 9, 2023
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trialSun Young Rha, Toni K Choueiri, Vsevolod B Matveev, et al.
Scientific Reports|July 5, 2026
Early systemic inflammatory-metabolic trajectory phenotypes are associated with survival outcomes in metastatic renal cell carcinoma treated with nivolumabOndřej Fiala, Tomas Buchler, Alexandr Poprach, et al.
The New England Journal of Medicine|March 21, 2014
Ribavirin for chronic hepatitis E virus infection in transplant recipientsNassim Kamar, Jacques Izopet, Simona Tripon, et al.
Frontiers in Immunology|July 15, 2026
Nivolumab in previously treated metastatic renal cell carcinoma: real-world data from the Czech Republic and SlovakiaOndřej Fiala, Michaela Tkadlecová, Tomas Buchler, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 17, 2023
Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH StudyCaroline Monchaud, Jean-Baptiste Woillard, Sabrina Crépin, et al.
Pageof 51